Evidence map›Paper›PMID 41899627›Full record

ArticleCancers2026

Pan-Cancer Targeted Sequencing Reveals Genomic Heterogeneity and Prognostic Subgroups in Urothelial Bladder Cancer.

Dimitar Ugrinovski, Skender Saidi, Viktor Stankov, Martina Ambardjieva, Slavica Josifovska, Anne-Katrin Koehler, Joerg Gabert, Sasho Panov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dimitar UgrinovskiLaboratory for Molecular Biology and Genomics, Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, 1000 Skopje, North Macedonia.
Skender SaidiUniversity Clinic for Urology, Clinical Center, Medical Faculty, Ss. Cyril and Methodius University, 1000 Skopje, North Macedonia.
Viktor StankovUniversity Clinic for Urology, Clinical Center, Medical Faculty, Ss. Cyril and Methodius University, 1000 Skopje, North Macedonia.
Martina AmbardjievaPHI University Clinic for Surgical Diseases St. Naum Ohridski, Skopje, Medical Faculty, Ss. Cyril and Methodius University, 1000 Skopje, North Macedonia.ORCID 0009-0008-7770-220X
Slavica JosifovskaLaboratory for Molecular Biology and Genomics, Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, 1000 Skopje, North Macedonia.ORCID 0000-0003-2551-0368
Anne-Katrin KoehlerPathoNext GmbH, 04103 Leipzig, Germany.
Joerg GabertPathoNext GmbH, 04103 Leipzig, Germany.
Sasho PanovLaboratory for Molecular Biology and Genomics, Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, 1000 Skopje, North Macedonia.ORCID 0000-0001-6742-5212

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bladder cancerFGFR3next-generation sequencingpan-cancer panelprognosisSTAG2TP53urothelial carcinoma

Identifiers

PMID41899627
PMCPMC13025778

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.